bpc-157 clinical trials registered - Peptide for Gut Health & Tissue Repair BPC-157 FDA Approval Status: Is
Description
Track your sleep for one week before starting BPC-157 to establish a baseline
Beck SE, Schwab JH, Rosenthal DI , Rosenberg AE, Grottkau BE
Unlike corticosteroid injections, BPC-157 does not appear to weaken tendon tissue or cause the long-term structural changes associated with repeated steroid use
Consult with your healthcare provider to determine if this is a suitable option
Mechanisms underlying cardiac protection include enhanced coronary angiogenesis, antioxidant effects reducing oxidative damage, anti-inflammatory modulation limiting inflammatory cell infiltration, and direct cardiomyocyte protection
